Nanosphere's Q4 Loss Rises on Higher Expenses

Feb 29, 2008

NEW YORK (GenomeWeb News) – Nanosphere reported after the market closed Thursday that its fourth-quarter revenues dipped slightly while its net loss jumped 56 percent on higher SG&A costs.

The Northbrook, Ill.-based molecular diagnostics firm, which went public through an IPO in early November, said that its revenues for the three-month period ended Dec. 31 were $188,186 compared to $203,345 in the fourth quarter of 2006. Most of its revenues were from grants and government contracts.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Testing Less Likely

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three for Immunotherapy

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

This Week in Genome Research

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Cancer-Fighting Zombies

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Main menu